Trials / Completed
CompletedNCT03963167
Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)
The Impact on the Health Status and Adherence in a Real-life Setting of Italian Patients With Chronic Obstructive Pulmonary Disease in Treatment With Trimbow® pMDI b.i.d.: a 12-month Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 661 (actual)
- Sponsor
- Chiesi Italia · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The mean objectives are to evaluate the impact of BDP/FF/G fixed combination on health-status and adherence
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BDP/FF/G fixed combination | Fixed combination of Inhaled Corticosteroid (ICS) / Long-acting β2-agonist (LABA) / long-acting muscarinic antagonist (LAMA) that contains Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium (G). |
Timeline
- Start date
- 2019-08-21
- Primary completion
- 2022-03-04
- Completion
- 2022-03-04
- First posted
- 2019-05-24
- Last updated
- 2026-02-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03963167. Inclusion in this directory is not an endorsement.